Share on LinkedInShare on LinkedIn

ARTICLE · 27 JUNE 2012

Business Method Patent Protection For Life Science Products

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

The recent Amazon.ca decision of the Federal Court of Appeal in 2011 reverses the Commissioner of Patent’s long-held belief that business method patents are unpatentable subject matter.

CanadaIntellectual Property

The recent Amazon.ca decision of the Federal Court of Appeal in 2011 reverses the Commissioner of Patent's long-held belief that business method patents are unpatentable subject matter. The implications of this decision for life sciences companies are far-reaching. The Amazon. ca decision has implications to medical use claims. Additionally, as a result of the Amazon.ca decision, life sciences companies should now consider taking advantage of business method patent protection generally associated with technologies relating to telecommunications, computer devices, software and e-commerce.

However, with advances in computer technology, an increasing number of life science companies are incorporating sophisticated hardware and software into their diagnostic, therapeutic or surgical products. In order to maximize revenues, it is critical that life science companies understand the issues relating to patenting software and business method technologies in Canada. The area

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from